Scibase AB Valuation
| SCIB Stock | SEK 0.35 0.02 5.41% |
Scibase AB seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Scibase AB from inspecting the company fundamentals such as Operating Margin of (2.59) %, return on equity of -0.9, and Shares Outstanding of 68.48 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Scibase AB's price fluctuation is out of control at this time. Calculation of the real value of Scibase AB is based on 3 months time horizon. Increasing Scibase AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Scibase AB's intrinsic value may or may not be the same as its current market price of 0.35, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.35 | Real 0.33 | Hype 0.35 |
The intrinsic value of Scibase AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Scibase AB's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Scibase AB helps investors to forecast how Scibase stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Scibase AB more accurately as focusing exclusively on Scibase AB's fundamentals will not take into account other important factors: Scibase AB Total Value Analysis
Scibase AB is at this time anticipated to have takeover price of 208.42 M with market capitalization of 195.86 M, debt of 356 K, and cash on hands of 65.61 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Scibase AB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
208.42 M | 195.86 M | 356 K | 65.61 M |
Scibase AB Investor Information
About 26.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.66. Scibase AB had not issued any dividends in recent years. The entity had 187:115 split on the 6th of May 2020. Based on the measurements of operating efficiency obtained from Scibase AB's historical financial statements, Scibase AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Scibase AB Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Scibase AB has an asset utilization ratio of 13.72 percent. This implies that the Company is making kr0.14 for each dollar of assets. An increasing asset utilization means that Scibase AB is more efficient with each dollar of assets it utilizes for everyday operations.Scibase AB Ownership Allocation
Scibase AB shows a total of 68.48 Million outstanding shares. Scibase AB maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Scibase AB Profitability Analysis
The company reported the revenue of 11.73 M. Net Loss for the year was (41.78 M) with profit before overhead, payroll, taxes, and interest of 11.23 M.About Scibase AB Valuation
The stock valuation mechanism determines Scibase AB's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Scibase AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Scibase AB. We calculate exposure to Scibase AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Scibase AB's related companies.SciBase Holding AB , a medical technology company, develops and sells skin cancer diagnostic instruments in Europe and internationally. The company was founded in 1998 and is headquartered in Stockholm, Sweden. Scibase Holding operates under Diagnostics Research classification in Sweden and is traded on Stockholm Stock Exchange. It employs 19 people.
8 Steps to conduct Scibase AB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Scibase AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Scibase AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Scibase AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Scibase AB's revenue streams: Identify Scibase AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Scibase AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Scibase AB's growth potential: Evaluate Scibase AB's management, business model, and growth potential.
- Determine Scibase AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Scibase AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Scibase Stock Analysis
When running Scibase AB's price analysis, check to measure Scibase AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scibase AB is operating at the current time. Most of Scibase AB's value examination focuses on studying past and present price action to predict the probability of Scibase AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scibase AB's price. Additionally, you may evaluate how the addition of Scibase AB to your portfolios can decrease your overall portfolio volatility.